Literature DB >> 1379171

Opposite vectorial secretion of insulin-like growth factor I and its binding proteins by pig Sertoli cells cultured in the bicameral chamber system.

M Skalli1, O Avallet, M Vigier, J M Saez.   

Abstract

A two-chamber system has been employed to investigate the vectorial secretion of insulin-like growth factor I (IGF-I) and its binding proteins (IGF-BPs) by pig Sertoli cells. The kinetics of transport of [3H]insulin as well as the transepithelial electrical resistance of filters coated with reconstituted basement membrane, in the absence of presence of Sertoli cells, indicated the formation of a functional barrier by Sertoli cells. The rates of diffusion of [125I]IGF-I or [125I]human CG were slower from the apical (AC) to the basal (BC) compartment than in the opposite direction. However, the IGF-I content and concentration in the BC was twice that seen in the AC. FSH increased the secretion of IGF-I in the BC, and therefore increased the BC/AC ratio. In contrast, most of the IGF-BPs, with apparent molecular sizes of 39-43, 34, 29 and 24 kDa, were secreted in the AC. FSH increased the secretion of IGF-BP 39-43 kDa (BP3). This is the first report of opposite vectorial secretion of IGF-I and its binding protein by any cell type.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379171     DOI: 10.1210/endo.131.2.1379171

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Estrogenic regulation of bicarbonate transporters from SLC4 family in rat Sertoli cells.

Authors:  Raquel L Bernardino; Ana D Martins; Tito T Jesus; Rosália Sá; Mário Sousa; Marco G Alves; Pedro F Oliveira
Journal:  Mol Cell Biochem       Date:  2015-06-23       Impact factor: 3.396

2.  Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis.

Authors:  B Drescher; H Lauke; M Hartmann; M S Davidoff; W Zumkeller
Journal:  Mol Pathol       Date:  1997-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.